Accéder au contenu
Merck

Synthesis, structure elucidation and antibacterial evaluation of new steroidal -5-en-7-thiazoloquinoxaline derivatives.

European journal of medicinal chemistry (2008-04-29)
Salman Ahmad Khan, Kishwar Saleem, Zaheer Khan
RÉSUMÉ

Some heterocyclic systems namely cholest-5-en-7-thiazolo[4,5-b]quinoxaline-2-yl-hydrazone] were synthesized by the reaction of cholest-5-en-7-one-thiosemicarbazone with 2,3-dichloroquinoxaline at 80 degrees C in high yield. The thiosemicarbazone derivatives were obtained by the condensation of the thiosemicarbazide with steroidal ketones. All the compounds have been characterized by means of elemental analyses, IR, 1H NMR and mass spectroscopic data. The in vitro antibacterial activity was evaluated by disk diffusion method and then the minimum inhibitory concentration (MIC) of compounds was determined against the culture of Escherichia coli. The results were compared with the standard drug chloramphenicol. The results showed that compounds 7 and 8 are better antibacterial agents as compared to chloramphenicol.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cholestérol, Sigma Grade, ≥99%
Sigma-Aldrich
Cholestérol, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
Cholestérol, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
SyntheChol® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
SAFC
Cholestérol, SyntheChol®
Sigma-Aldrich
2,3-Dichloroquinoxaline, 96%
Sigma-Aldrich
Cholestérol, tested according to Ph. Eur.